EUVIMEDEUVIMED entdecken
Crossref

Fibroblast-Mediated MMP2 Contribution to Nonresponse in Anti-TNFα Therapy for Crohn’s Disease

Danshu Wang iD, Dehao Zhu, Xiangyu Zhao, Jiaxin Wang, Haiming Zhuang, Yao Zhang, Duowu Zou iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Danshu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Crohn Disease, Fibroblasts, Matrix Metalloproteinase 2, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the transformative impact of biologics on the treatment of inflammatory bowel disease (IBD) in recent years, a substantial proportion of patients remain unresponsive to these advanced therapies. Overcoming resistance remains a significant clinical challenge, largely due to the incomplete understanding of its underlying mechanisms. This study explores the role of extracellular matrix (ECM) remodeling in the development of resistance to anti-TNFα therapy.

Methods

Using public single-cell and bulk transcriptomic datasets, combined with in vitro primary cell experiments and multiplex immunofluorescence validation, we investigated key factors contributing to therapy failure.

Results

Transcriptomic analysis revealed that ECM-related pathways were enriched in Crohn’s disease patients and associated with resistance to anti-TNFα therapy. Single-cell analysis identified Fibroblast 2 (CD81+ fibroblasts) as the major ECM-related stromal subpopulation, exhibiting the highest capacity for ECM secretion and degradation. Matrix metalloproteinase-2 (MMP2) was identified as a key protease highly expressed in this subset, showing close interaction with macrophages. Co-culture of primary fibroblasts and macrophages led to increased release of inflammatory mediators such as TNFα and IL-6, which was partially reduced by MMP2 inhibition, suggesting a potential regulatory role of MMP2 in fibroblast-macrophage crosstalk. Spatial transcriptomics and multiplex immunofluorescence further supported the spatial colocalization and interaction of fibroblasts, macrophages, and MMP2 within the tissue microenvironment.

Conclusions

This study highlights the association of pathogenic fibroblasts and ECM remodeling in anti-TNFα therapy failure, identifies MMP2 as a potential target, and suggests that combination therapy may offer a potential strategy for patients with treatment resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFibroblastsMatrix Metalloproteinase 2Tumor Necrosis Factor-alphaDrug ResistanceTumor Necrosis Factor InhibitorsHumansExtracellular MatrixMacrophagesCoculture TechniquesCells, Cultured

Stichwörter der Autor:innen

Crohn’s diseaseECM remodelingMMP2anti-TNFαfibroblaststherapy

Substanzen

Matrix Metalloproteinase 2Tumor Necrosis Factor-alphaMMP2 protein, humanTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

ORCID-Profile: Danshu Wang, Duowu Zou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, D., Zhu, D., Zhao, X., Wang, J., Zhuang, H., Zhang, Y., & Zou, D. (2026). Fibroblast-Mediated MMP2 Contribution to Nonresponse in Anti-TNFα Therapy for Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf263

Vancouver

Wang D, Zhu D, Zhao X, Wang J, Zhuang H, Zhang Y, et al. Fibroblast-Mediated MMP2 Contribution to Nonresponse in Anti-TNFα Therapy for Crohn’s Disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf263

BibTeX
@article{Wang2026,
  author = {Wang, Danshu and Zhu, Dehao and Zhao, Xiangyu and Wang, Jiaxin and Zhuang, Haiming and Zhang, Yao and Zou, Duowu},
  title = {Fibroblast-Mediated MMP2 Contribution to Nonresponse in Anti-TNFα Therapy for Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf263}
}
Kostenlos starten →